Health Care: Drugs

NovaBay Pharmaceuticals Inc (NBY: AMEX)

$2.72 -0.17 | -5.88%
05/25/16 - 12:30 PM ET
Company Profile
Price and Volume
Recent Price 2.89
52 Week High 26.25
52 Week Low 1.63
Avg. Daily Vol. (Mil) 0.03
Beta (3 year) -0.85
Share Related Items
Mkt Cap (Mil) 26.46
Shares Out (Mil) 9.15
Float (Mil) 2.66
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.70
Current Ratio 1.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 4.76
Price/Book 0.00
Price/Cash Flow -1.40
Per Share Data
Earnings -5.97
Sales 0.61
Book Value 0.00
Cash Flow -2.10
Business Summary
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
General Information
5980 Horton Street
Suite 550
Emeryville, CA 94608
Industry : Drugs
Sector: Health Care
Employees: 23
CEO: Mark M. Sieczkarek
Short Interest
Current Month (Mil) 0.18
Previous Month (Mil) 0.12
Short Interest Ratio (Days) 4.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -393.60
Return on Investments 458.20
Gross Margin 71.90
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NBY

Latest NBY Headlines from TheStreet

More Financial News for NBY

Press Releases for NBY

See All Press Releases

Partner Headlines for NBY

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter